Advertisement
Screener

electroCore, Inc. (ECOR) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

2.8 / 5 stars · 41/73 Roast Me

electroCore, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

electroCore, Inc. (ECOR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $4.31 per share for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-19.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2026-03-19

  • electroCore, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2023-03-31 was $3.46, a 57.28% decline year-over-year.
  • electroCore, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2022-03-31 was $8.10, a 482.73% increase year-over-year.
  • electroCore, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2021-03-31 was $1.39, a 9.45% increase year-over-year.
  • electroCore, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2020-06-30 was $0.90.
  • electroCore, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2024 was $4.31, a 9.11% increase from fiscal 2023.
  • electroCore, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $3.95, a 45.14% decline from fiscal 2022.
  • electroCore, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $7.20, a 63.64% decline from fiscal 2021.
  • electroCore, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2021 was $19.80, a 1920.41% increase from fiscal 2020.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month as first filedShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month as first filedShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month as first filed
2024-12-31$4.31
10-K · filed 2026-03-19
2024-09-30$4.31
10-Q · filed 2024-11-13
2023-12-31$3.95
10-K · filed 2025-03-12
2023-09-30$3.95
10-Q · filed 2024-11-13
2023-06-30$3.46
10-Q · filed 2024-08-07
2023-03-31$3.46
10-Q · filed 2024-05-08
2022-12-31$7.20
10-K · filed 2024-03-13
2022-09-30$0.53
10-Q · filed 2023-11-08
2022-06-30$7.95
10-Q · filed 2023-08-09
$0.53
10-Q · filed 2022-08-04
2022-03-31$8.10
10-Q · filed 2023-05-03
$0.54
10-Q · filed 2022-05-05
2021-12-31$19.80
10-K · filed 2023-03-08
$1.32
10-K · filed 2022-03-10
2021-09-30$1.33
10-Q · filed 2022-11-03
2021-06-30$1.36
10-Q · filed 2022-08-04
2021-03-31$1.39
10-Q · filed 2022-05-05
2020-12-31$0.98
10-K · filed 2022-03-10
2020-09-30$0.98
10-Q · filed 2021-11-04
2020-06-30$0.90
10-Q · filed 2020-08-13
$0.98
10-Q · filed 2021-08-05
2020-03-31$1.27
10-Q · filed 2021-05-06
2019-12-31$3.39
10-K · filed 2021-03-11
2019-09-30$4.44
10-Q · filed 2020-11-12
2019-03-31$4.89
10-Q · filed 2020-05-15
2018-12-31$2.50
10-K · filed 2020-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Neuraxis, INC (NRXS)United States$0.097B
Nexalin Technology, Inc. (NXL)United States$0.094B
Vivani Medical, Inc. (VANI)United States$0.111B
Streamex Corp. (STEX)United States$0.089B-0.19
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
Outset Medical, Inc. (OM)United States$0.059B-1.09
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
EDAP TMS SA (FOCL)$0.171B
IRIDEX CORP (IRIX)United States$0.011B